Related Experiment Video
Updated: Jun 9, 2025
09:03
Analysis of Human Natural Killer Cell Metabolism
Published on: June 22, 2020
6.8K
Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments
Philippa R Kennedy1, Upasana Sunil Arvindam1, Shee Kwan Phung1
1Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Science Advances
|October 30, 2024
Summary
Hypoxia impairs natural killer (NK) cell immunotherapy in tumors. Preactivation and novel tri-specific engager molecules overcome this limitation, enhancing NK cell anti-tumor activity in low-oxygen environments.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Metabolism
Background:
- Solid tumors often exhibit limited oxygen (hypoxia), which impedes effective natural killer (NK) cell immunotherapy.
- NK cell cytotoxicity and function are significantly reduced under hypoxic conditions, impacting treatment success.
Purpose of the Study:
- To investigate the mechanisms behind NK cell dysfunction in hypoxia.
- To identify strategies for enhancing NK cell activity in the hypoxic tumor microenvironment.
Main Methods:
- NK cells were cultured and tested under varying oxygen levels (hypoxia vs. normoxia).
- Cytotoxicity, transcriptional changes, metabolism, and protein expression were analyzed.
- Interleukin-15 (IL-15) and preactivation strategies (feeder cells with IL-21 and 4-1BBL) were employed.
- Tri-specific killer engager molecules delivering IL-15 were evaluated.
Main Results:
- Hypoxia led to impaired NK cell cytotoxicity, transcriptional dysregulation, and metabolic changes.
- IL-15 treatment improved cytotoxicity, but preactivation was more effective, preserving NK cell function and stress resistance.
- A deficit in CD122/IL-2Rβ under hypoxia affected IL-15 signaling.
- Tri-specific killer engagers successfully enhanced NK cell cytotoxicity in hypoxia, bypassing the CD122 deficit.
Conclusions:
- NK cell function is significantly compromised by tumor hypoxia at multiple levels.
- Preactivation strategies and targeted IL-15 delivery via tri-specific engagers offer promising therapeutic avenues to restore NK cell anti-tumor activity in hypoxic tumors.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
853
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
853
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:28Cells of the Innate Immune Response
1.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K